1887
Research articles Open Access
Like 0

Abstract

The first pneumococcal vaccine targeting the youngest age groups, a seven-valent conjugate vaccine (PCV7), was licensed in Europe in 2001. Since then several European countries have introduced PCV7 in their childhood vaccination schedules. Still, information on vaccination schemes, vaccine uptake and impact of vaccine introduction is scarce in Europe. The following article summarises the characteristics of national pneumococcal vaccination programmes for children in 32 European countries and provides an estimate of vaccine use based on sales data for 22 countries between 2001 and 2007. There were wide variations in the recommended PCV7 vaccination schemes and in PCV7 use. High vaccine uptake was not always related to the presence of a national vaccination programme.

Loading

Article metrics loading...

/content/10.2807/ese.14.12.19159-en
2009-03-26
2017-11-24
http://instance.metastore.ingenta.com/content/10.2807/ese.14.12.19159-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/14/12/art19159-en.htm?itemId=/content/10.2807/ese.14.12.19159-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error